ZA85239B - Controlled release liquid dosage formulations for pharmaceuticals - Google Patents
Controlled release liquid dosage formulations for pharmaceuticalsInfo
- Publication number
- ZA85239B ZA85239B ZA85239A ZA85239A ZA85239B ZA 85239 B ZA85239 B ZA 85239B ZA 85239 A ZA85239 A ZA 85239A ZA 85239 A ZA85239 A ZA 85239A ZA 85239 B ZA85239 B ZA 85239B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceuticals
- controlled release
- liquid dosage
- dosage formulations
- release liquid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57046984A | 1984-01-13 | 1984-01-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA85239B true ZA85239B (en) | 1985-08-28 |
Family
ID=24279767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA85239A ZA85239B (en) | 1984-01-13 | 1985-01-10 | Controlled release liquid dosage formulations for pharmaceuticals |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0169236A1 (fr) |
JP (1) | JPS61500910A (fr) |
AU (1) | AU3835885A (fr) |
CA (1) | CA1239347A (fr) |
ES (1) | ES8605975A1 (fr) |
GR (1) | GR850069B (fr) |
IL (1) | IL74049A0 (fr) |
IT (1) | IT1184309B (fr) |
NZ (1) | NZ210785A (fr) |
WO (1) | WO1985003000A1 (fr) |
ZA (1) | ZA85239B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987005505A1 (fr) * | 1986-03-21 | 1987-09-24 | Eurasiam Laboratories, Inc. | Compositions pharmaceutiques |
SE8605515D0 (sv) * | 1986-12-22 | 1986-12-22 | Astra Laekemedel Ab | A liquid dosage form for oral administration of a pharmaceutically active substance |
FI77573C (fi) * | 1987-05-08 | 1989-04-10 | Orion Yhtymae Oy | Ny konsistens. |
US4853229A (en) * | 1987-10-26 | 1989-08-01 | Alza Corporation | Method for adminstering tiny pills |
US5030454A (en) * | 1987-10-26 | 1991-07-09 | Alza Corporation | Method for delivering drug in tiny pills in liquid carrier |
US5296236A (en) * | 1988-09-16 | 1994-03-22 | Recordati S.A., Chemical And Pharmaceutical Company | Controlled release therapeutic system for a liquid pharmaceutical formulations |
IT1226940B (it) * | 1988-09-16 | 1991-02-22 | Recordati Chem Pharm | Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide |
US5202128A (en) * | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
DE69220317T2 (de) * | 1991-10-01 | 1997-10-16 | Takeda Chemical Industries Ltd | Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe |
US5160742A (en) * | 1991-12-31 | 1992-11-03 | Abbott Laboratories | System for delivering an active substance for sustained release |
IL104093A (en) * | 1991-12-31 | 1999-06-20 | Abbott Lab | Prolamine is expected to mask the taste of drugs given orally |
AU4198793A (en) † | 1992-07-24 | 1994-01-27 | Takeda Chemical Industries Ltd. | Microparticle preparation and production thereof |
US5744164A (en) * | 1994-12-16 | 1998-04-28 | Nestec S.A. | Sustained release microparticulate caffeine formulation |
FR2791888B1 (fr) * | 1999-04-06 | 2004-10-08 | Ethypharm Lab Prod Ethiques | Suspension pharmaceutique buvable |
US6794411B1 (en) | 1999-04-06 | 2004-09-21 | Laboratoire Des Produits Ethiques Ethypharm | Drinkable ibuprofen pharmaceutical suspension |
FR2821745B1 (fr) * | 2001-03-09 | 2004-07-02 | Ethypharm Lab Prod Ethiques | Granules et granules enrobes au gout masque |
WO2004096175A2 (fr) * | 2003-04-30 | 2004-11-11 | Ranbaxy Laboratories Limited | Compositions au gout masque et leurs procedes de preparation |
WO2016037131A1 (fr) | 2014-09-05 | 2016-03-10 | Symbiomix Therapeutics, Llc | Secnidazole utilisé dans le traitement d'une vaginose bactérienne |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2805977A (en) * | 1955-01-04 | 1957-09-10 | Smith Kline French Lab | Sustained release pharmaceutical preparation |
US3265629A (en) * | 1958-12-22 | 1966-08-09 | Ncr Co | Coating by phase separation |
US3432593A (en) * | 1963-09-18 | 1969-03-11 | Key Pharm Inc | Delayed and sustained release type pharmaceutical preparation |
-
1985
- 1985-01-08 NZ NZ210785A patent/NZ210785A/en unknown
- 1985-01-09 JP JP60500315A patent/JPS61500910A/ja active Pending
- 1985-01-09 WO PCT/US1985/000042 patent/WO1985003000A1/fr not_active Application Discontinuation
- 1985-01-09 EP EP85900864A patent/EP0169236A1/fr not_active Withdrawn
- 1985-01-09 AU AU38358/85A patent/AU3835885A/en not_active Abandoned
- 1985-01-10 GR GR850069A patent/GR850069B/el unknown
- 1985-01-10 ZA ZA85239A patent/ZA85239B/xx unknown
- 1985-01-11 IT IT19086/85A patent/IT1184309B/it active
- 1985-01-11 ES ES539500A patent/ES8605975A1/es not_active Expired
- 1985-01-11 CA CA000471918A patent/CA1239347A/fr not_active Expired
- 1985-01-13 IL IL74049A patent/IL74049A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPS61500910A (ja) | 1986-05-08 |
AU3835885A (en) | 1985-07-30 |
ES539500A0 (es) | 1986-04-01 |
GR850069B (fr) | 1985-05-03 |
IL74049A0 (en) | 1985-04-30 |
CA1239347A (fr) | 1988-07-19 |
WO1985003000A1 (fr) | 1985-07-18 |
ES8605975A1 (es) | 1986-04-01 |
NZ210785A (en) | 1987-11-27 |
EP0169236A1 (fr) | 1986-01-29 |
IT1184309B (it) | 1987-10-28 |
IT8519086A0 (it) | 1985-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL80643A0 (en) | Controlled release pharmaceutical compositions | |
EP0184910A3 (en) | Device for controlled release drug delivery | |
ZA828797B (en) | Pharmaceutical formulation | |
GR880300019T1 (en) | Confectionery delivery system for actives | |
IL76651A (en) | Release system for two or more active substances | |
EP0251459A3 (en) | Controlled release pharmaceutical composition | |
GB8501930D0 (en) | Delivery & dosage device | |
EP0257786A3 (en) | Dosage form for delivering acid sensitive beneficial agent | |
ZA85239B (en) | Controlled release liquid dosage formulations for pharmaceuticals | |
EP0070525A3 (en) | Pharmaceutical preparations for external use | |
PH20391A (en) | Controlled release pharmaceutical preparations | |
DE3264782D1 (en) | Medicinal formulation | |
GB2155335B (en) | Device for sustained release of medicinal substances | |
ZA824513B (en) | Pharmaceutical formulations | |
ZA857643B (en) | Release system for two or more active substances | |
ZA855365B (en) | Pharmaceutical formulations for ceftazidime | |
EP0196002A3 (en) | Tablet composition for drug combinations | |
ZA859077B (en) | Pharmaceutical compounds | |
GB8402574D0 (en) | Pharmaceutical formulation | |
IE850071L (en) | Controlled release pharmaceutical formulations | |
IL91357A0 (en) | Pharmaceutical formulations containing certain benzimi-azolylmethyl benzenamides | |
GB8425314D0 (en) | Pharmaceutical formulation | |
GB8423634D0 (en) | Pharmaceutical formulation | |
GB8409705D0 (en) | Pharmaceutical formulation | |
GB8419107D0 (en) | Pharmaceutical formulations |